JAG1 and cancer: COMP increases the interaction between Notch3 and its ligand Jagged1, causing higher activation of Jagged1-Notch3 signaling and cross-reactivity with other important cancer-related pathways, such as AKT and β-catenin, resulting in the generation of a large number of cancer stem cells [105] (Figure 5).